Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Reardon, David
Item TypeName
Academic Article Phase II trial of murine (131)I-labeled antitenascin monoclonal antibody 81C6 administered into surgically created resection cavities of patients with newly diagnosed malignant gliomas.
Academic Article Immunotherapy against angiogenesis-associated targets: evidence and implications for the treatment of malignant glioma.
Academic Article Monoclonal antibodies for brain tumour treatment.
Academic Article Monoclonal antibody blockade of IL-2 receptor a during lymphopenia selectively depletes regulatory T cells in mice and humans.
Concept Immunotherapy
Academic Article An update on vaccine therapy and other immunotherapeutic approaches for glioblastoma.
Academic Article Immunotherapy advances for glioblastoma.
Academic Article Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients.
Academic Article Re-defining response and treatment effects for neuro-oncology immunotherapy clinical trials.
Academic Article Programmed death ligand 1 (PD-L1) as an immunotherapy target in patients with glioblastoma.
Academic Article Rindopepimut vaccine and bevacizumab combination therapy: improving survival rates in relapsed glioblastoma patients?
Academic Article Prospects of immune checkpoint modulators in the treatment of glioblastoma.
Academic Article An Update on the Role of Immunotherapy and Vaccine Strategies for Primary Brain Tumors.
Academic Article Immunotherapy response assessment in neuro-oncology: a report of the RANO working group.
Academic Article Introduction.
Academic Article Immunotherapy for neuro-oncology: the critical rationale for combinatorial therapy.
Academic Article Checkpoint inhibition in meningiomas.
Academic Article A methods study to define the performance specifications of MHC tetramer assays for immune monitoring of tumor immunotherapy.
Academic Article Advanced MRI assessment to predict benefit of anti-programmed cell death 1 protein immunotherapy response in patients with recurrent glioblastoma.
Academic Article The development of dendritic cell vaccine-based immunotherapies for glioblastoma.
Academic Article Immunomodulation for glioblastoma.
Academic Article Preclinical investigation of combined gene-mediated cytotoxic immunotherapy and immune checkpoint blockade in glioblastoma.
Academic Article Immunotherapy for glioblastoma: on the sidelines or in the game?
Academic Article Concepts for Immunotherapies in Gliomas.
Academic Article Improved Risk-Adjusted Survival for Melanoma Brain Metastases in the Era of Checkpoint Blockade Immunotherapies: Results from a National Cohort.
Academic Article Immunotherapy for glioblastoma: going viral.
Academic Article Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain.
Academic Article Pseudoprogression: fact or wishful thinking in neuro-oncology?
Academic Article Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma.
Academic Article Emerging Immunotherapies for Malignant Glioma: From Immunogenomics to Cell Therapy.
Search Criteria
  • Immunotherapy
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.